The MRP model was identified as an effective predictive model for risk of MP-related hepatitis in MP pneumonia pediatric patients, especially in infants and toddlers (age, 0–36 months) with low MP-IgM titer (1:160–1:320). This evidence concerns the gene CD40LG and Hepatitis.